To evaluate the prognostic value of Vimentin, TP53 and Podoplanin in cervical cancer, we then examined the correlation between the expression of Vimentin, TP53 and Podoplanin and patients’ survival using the Kaplan–Meier estimate and log-rank test. This evidence concerns the gene PDPN and cervical cancer.